Basal Cell Carcinoma — Trials

Basal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

361 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 32
Ph III recruiting: 3
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 16.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (25)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05212246	Basal Cell Carcinoma Chemoprevention Trial(B3C)	not yet recruiting	Phase 3	1,630	VA Office of Research and DevelopmentFED	1	Sep 29, 2026	clinicaltrials

Data updated 17 hours agoSource updated Sep 29, 2026source: clinicaltrials